2. Profile
  3. Christopher Holden

Christopher Holden MD

Christopher Holden
Designation
  • Program Director, Addiction Medicine Fellowship
  • Director of Addiction Psychiatry
  • Assistant Professor of Clinical Psychiatry
  • Department of Psychiatry – University of Illinois College of Medicine
  • UI Health
Contact Information
  • cholde1 [at] uic.edu
  • (312) 996-8770
Website

Dr. Holden is the Director of Addiction Psychiatry. He treats a variety of psychiatric conditions, and he specializes in the treatment of patients with co-occurring psychiatric and substance use disorders. He works with patients in the outpatient mental health clinic as well as the hospital’s inpatient medical, surgical, and psychiatric units.

  • psychiatry

    Dr. Holden believes in taking an integrated approach to the treatment of psychiatric conditions. Patients are most likely to recover from psychiatric and addictive disorders when they are addressed simultaneously, in particular with multiple complementary approaches, which can include medication and psychotherapy. He is published in the fields of addiction medicine and basic biomedical research.

  • Salsitz EA, Holden CC, Tross S, Nugent A: “Transitioning Stable Methadone Maintenance Patients to Buprenorphine Maintenance.” J Addict Med. 2010 Jun 4(2):88-92.

    Tomatsu S, Orii KO, Fleming RE,Holden CC, Waheed A, Britton RS, Gutierrez MA, Velez-Castrillon S, Bacon BR, Sly WS: “Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis.” Proc Natl Acad Sci USA. 2003 Dec 23;100(26):15788-93.

    Tomatsu S, Orii KO, Vogler C, Grubb JH, Snella EM, Gutierrez M, Dieter T, Holden CC, Sukegawa K, Orii T, Kondo N, Sly WS: “Production of MPS VII mouse (Gus(tm(hE540A x mE536A)Sly)) doubly tolerant to human and mouse beta-glucuronidase.” Hum Mol Genet. 2003 May 1;12(9):961-73.

    Fleming RE, Holden CC, Tomatsu S, Waheed A, Brunt EM, Britton RS, Bacon BR, Roopenian DC, Sly WS: “Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis.” Proc Natl Acad Sci USA. 2001 Feb 27;98(5):2707-11.

    Fleming RE, Migas MC, Holden CC, Waheed A, Britton RS, Tomatsu S, Bacon BR, Sly WS: “Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis.” Proc Natl Acad Sci USA. 2000 Feb 29;97(5):2214-9.

    National Presentations
    “Benzodiazepine Use, Misuse, Addiction and Treatment.” Symposium Co-Speaker and Co-Coordinator, American Society of Addiction Medicine 44th Annual Medical-Scientific Conference, 4/27/2013